Roche Loses First Accutane Trial, Jury Awards $2.5M

Law360, New York (May 29, 2007, 12:00 AM EDT) -- Swiss drug maker Roche Holding AG has lost the first of hundreds of cases set for trial over its acne medication, with a jury awarding $2.5 million to an Alabama man who developed bowel disease after taking the drug.

The jury in New Jersey's Superior Court in Atlantic City found the pharmaceutical giant had failed to adequately warn users of the dangerous side effects of Accutane since the drug came on the market in 1982.

The jury also awarded the plaintiff, Andrew McCarrell, 36, an additional...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.